ArriVent BioPharma, Inc. Common Stock
Symbol: AVBP (NASDAQ)
19.36
▲ (2.60%) 0.490
Company Description:
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
Key Stats
- Today's Open: $18.89
- Today's High: $19.365
- Today's Low: $18.816
- Today's Volume: 69.17K
- Yesterday Close: $18.87
- Yesterday High: $19.66
- Yesterday Low: $18.35
- Yesterday Volume: 424.62K
- Last Min Volume: 3
- Last Min High: $19.36
- Last Min Low: $19.36
- Last Min VWAP: $19.36
Company Profile
- Name: ArriVent BioPharma, Inc. Common Stock
- Website: https://www.arrivent.com
- Listed Date: 2024-01-26
- Location: NEWTOWN SQUARE, PA
- Market Status: Active
- CIK Number: 0001868279
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $765.54M
- Round Lot: 100
- Outstanding Shares: 40.57M
- Asset Type: CS
RECENT FILINGS FOR AVBP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | SCHEDULE 13D/A | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-13 | SCHEDULE 13G | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-07-21 | 8-K | View |
| 2025-07-15 | 4 | View |
| 2025-07-02 | 424B5 | View |
| 2025-07-02 | 8-K | View |
| 2025-07-01 | 424B5 | View |
| 2025-06-23 | 8-K | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G | View |
| 2025-05-12 | 10-Q | View |
Latest News on AVBP